✦ LIBER ✦

The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancer

✍ Scribed by Werner R. Bezwoda; Charles Hesdorffer

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 366 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19861015)58:8<1621::aid-cncr2820580806>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin plus alkylating agents in the

Adriamycin plus alkylating agents in the treatment of metastatic breast cancer

✍ Jacob J. Lokich; Arthur T. Skarin; Robert J. Mayer; I. ÀIg Cr Henderson; Ronald 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

A phase II study of paclitaxel plus carb

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi

Evaluation of the continuous infusion of

Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer a collaborative north central cancer treatment group/mayo clinic phase ii study

✍ James E. Krook; Charles L. Loprinzi; Daniel J. Schaid; Carl G. Kardinal; James A 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 2 views

Total androgen blockade with the use of

Total androgen blockade with the use of orchiectomy and nilutamide (anandron) or placebo as treatment of metastatic prostate cancer

✍ R. A. Janknegt; Anandron International Study Group 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

A pilot study on the use of the proMACE-

A pilot study on the use of the proMACE-cytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma

✍ Luca Baldini; Andrea Guffanti; Paolo Gobbi; Mariangela Colombi; Massimo Federico 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Background: The role of intensive conventional dose chemotherapy in advanced low grade non-hodgkin's lymphomas is a matter of debate. the gruppo italiano per lo studio dei linfomi conducted a study to evaluate the efficacy and toxicity of a third-generation polychemotherapeutic regimen, promace-